Excess accumulated NAD+ sequentially triggers the persistent activation of multiple NAD+-reliant intracellular signaling cascades
For most practical purposes, five half-lives represents complete clearance
Bilodeau JF, Patenaude A, Piedboeuf B, Carrier C, Petrov P, Faure R, Mirault ME
FoxOs function synergistically to promote glucose production
The pharmaceutical formulation disclosed herein may be used in: (i) the prevention and/or treatment of any form of diabetes and associated symptoms, such as hyperglycaemia, type 2 diabetes, impaired glucose tolerance, type 1 diabetes, non-insulin dependent diabetes, maturity onset diabetes of the young (MODY), gestational diabetes and/or for the reduction of HbA1c